Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett’s esophagus (BE), is present in roughly seven percent of middle-aged adults, less than one percent of BE patients will progress to EAC, making it difficult to determine which individuals are at risk of developing this deadly cancer.
Joined Cath Procedures Turn the Table on SAVR-CABG
PARIS — For patients with severe aortic stenosis (AS) and concomitant obstructive coronary artery disease (CAD), a percutaneous combined intervention worked surprisingly well relative to
May 15, 2024